Literature DB >> 34351519

Choroidal vascularity index in pseudoexfoliative glaucoma.

Melisa Zisan Karslioglu1, Cem Kesim1, Ozum Yucel2, Ayse Yildiz Tas1, Safak Torun3, Cigdem Altan2, Afsun Sahin4.   

Abstract

PURPOSE: To evaluate choroidal vascular involvement in pseudoexfoliative glaucoma (PEXG) by applying the choroidal vascularity index (CVI) to optic coherence tomography (OCT) images.
METHODS: Seventy-eight eyes from 40 subjects were included the study. Group 1 included healthy eyes (n = 20), group 2 eyes with PEX (n = 16), and group 3 eyes with PEXG (n = 42). OCT imaging of macular and peripapillary regions and retinal nerve fiber layer (RNFL) analyses were performed. CVI was calculated using ImageJ software.
RESULTS: The mean age was 64.89 ± 5.8, 71.2 ± 7.8, and 68.24 ± 7.4 years in groups 1, 2, and 3, respectively (p = 0.046). There were no significant differences between the groups in terms of sex (p = 0.777). In macula, mean CVI rates were 66.97 ± 1.9%, 64.23 ± 1.2%, and 64.63 ± 1.6%, and in the peripapillary areas, mean CVI rates were 67.04 ± 1.5%, 65.20 ± 1.5%, and 64.14 ± 2.1% in groups 1, 2, and 3, respectively (group 1 vs. group 2 and 3, p = 0.000; group 2 vs. group 3, p > 0.05). The decrease in average RNFL thickness was statistically significant in group 3 compared to groups 1 and 2.
CONCLUSION: CVI could be used to assess choroidal vascular changes in ocular diseases. CVI was found to be reduced in PEX and PEXG, indicating an ocular vascular involvement in pseudoexfoliative process.
© 2021. The Author(s), under exclusive licence to Springer Nature B.V.

Entities:  

Keywords:  Choroidal vascularity index; Pseudoexfoliation syndrome; Pseudoexfoliative glaucoma

Year:  2021        PMID: 34351519     DOI: 10.1007/s10792-021-01990-z

Source DB:  PubMed          Journal:  Int Ophthalmol        ISSN: 0165-5701            Impact factor:   2.031


  44 in total

1.  Outcomes of phacoemulsification in patients with and without pseudoexfoliation syndrome.

Authors:  Bradford J Shingleton; James Heltzer; Mark W O'Donoghue
Journal:  J Cataract Refract Surg       Date:  2003-06       Impact factor: 3.351

2.  Exfoliation syndrome-the most common identifiable cause of open-angle glaucoma.

Authors:  R Ritch
Journal:  J Glaucoma       Date:  1994       Impact factor: 2.503

Review 3.  Exfoliation syndrome.

Authors:  R Ritch; U Schlötzer-Schrehardt
Journal:  Surv Ophthalmol       Date:  2001 Jan-Feb       Impact factor: 6.048

4.  Exfoliation Syndrome: A Historical Perspective.

Authors:  Ahti Tarkkanen
Journal:  J Glaucoma       Date:  2018-07       Impact factor: 2.503

5.  Weill-Marchesani Syndrome with Secondary Angle Closure Glaucoma.

Authors:  Faisal Thattaruthody; Madhuri Akella; Deepika Dhingra; Surinder Singh Pandav; Sushmita Kaushik
Journal:  J Glaucoma       Date:  2019-10-29       Impact factor: 2.503

Review 6.  [Pseudoexfoliation syndrome and pseudoexfoliation glaucoma].

Authors:  C Schweitzer
Journal:  J Fr Ophtalmol       Date:  2018-01-10       Impact factor: 0.818

Review 7.  Exfoliation syndrome: a disease with an environmental component.

Authors:  Samantha Dewundara; Louis R Pasquale
Journal:  Curr Opin Ophthalmol       Date:  2015-03       Impact factor: 3.761

Review 8.  Why is glaucoma associated with exfoliation syndrome?

Authors:  Robert Ritch; Ursula Schlötzer-Schrehardt; Anastasios G P Konstas
Journal:  Prog Retin Eye Res       Date:  2003-05       Impact factor: 21.198

9.  Late in-the-bag spontaneous intraocular lens dislocation: evaluation of 86 consecutive cases.

Authors:  Don Davis; Jacob Brubaker; Ladan Espandar; Jack Stringham; Alan Crandall; Liliana Werner; Nick Mamalis
Journal:  Ophthalmology       Date:  2009-04       Impact factor: 12.079

Review 10.  [Pseudoexfoliation syndrom].

Authors:  Piotr Piejko; Agnieszka Ścisłowicz; Mateusz Nowak; Paulina Renke; Piotr Chaniecki
Journal:  Pol Merkur Lekarski       Date:  2018-10-29
View more
  1 in total

1.  Choroidal Vascularity Index Changes After Exercise in Patients With Glaucoma.

Authors:  Dan Cheng; Jia Fang; Weiqian Gao; Minhui Wu; Yilin Qiao; Kaiming Ruan; Hengli Lian; Jiner Cen; Lin Fu; Lijun Shen; Li Nie
Journal:  Front Physiol       Date:  2022-03-30       Impact factor: 4.566

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.